Results 151 to 160 of about 518,587 (296)

Pathophysiological Mechanisms of Emaciation Syndrome in Plectropomus leopardus: Insights From Histology and Transcriptomics

Animal Research and One Health, EarlyView.
Integrated phenotypic, histological, transcriptomic, and validation analyses reveal that emaciation syndrome in Plectropomus leopardus is associated with intestinal structural damage, hepatic metabolic remodeling, and muscle protein degradation, highlighting coordinated multi‐tissue alterations underlying disease progression.
Zhihao Zhang, Bo Wang, Mengya Wang, Haizhan Tang, Mingjian Liu, Da Zheng, Zhongyi Zhai, Jiahang Li, Jinyang Xie, Chaofan Jin, Jingjie Hu, Zhenmin Bao   +11 more
wiley   +1 more source

Successful Management of Hypertriglyceridemia-Induced Acute Pancreatitis in Resource-Limited Setting: A Case Report and Brief Review of the Literature. [PDF]

Clin Case Rep
Sankhi MN, Rajbhandari S, Rayamajhi A, Dhakal P, Adhikari N, Singh SK.   +5 more
europepmc   +1 more source

Association Between Triglyceride-Glucose Index and Lung Function Parameters in the General Population Undergoing Health Examinations [PDF]

Yu Yang,1,2 Shuqi Wang,1,3 Boying Jia,1,3 Shuchun Chen1,3 1Department of Internal Medicine, Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of Pharmacy, The Second Hospital of Hebei Medical University, Shijiazhuang, People’
Yang Y, Wang S, Jia B, Chen S
core  

Indices of Systemic Inflammation Are Elevated in Women With Evidence of Metabolic Syndrome After Anterior Cruciate Ligament Reconstruction

Arthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To investigate the association between metabolic syndrome (MetSy) and systemic indices of the immune system and inflammation after anterior cruciate ligament reconstruction (ACLR). Methods This retrospective study included adult patients (≥18 years) who underwent ACLR at a single academic institution between 2009 and 2022.
Marina Abdelshahid, Sonu Bae, Hayden Price, Hawraa Al Janabi, Catherine Rock, Anthony Mantor, Nicholas Apseloff, Christopher C. Kaeding, Robert A. Magnussen, David C. Flanigan, Tyler Barker   +10 more
wiley   +1 more source

Effect of pemafibrate on LDL-cholesterol properties in type 2 diabetes and hypertriglyceridemia by lipid management status: PARM-T2D post hoc analysis. [PDF]

J Diabetes Investig
Kitsunai H, Kito K, Omori K, Cho KY, Nakamura A, Takeuchi J, Nagai S, Sakuma I, Nomoto H.   +8 more
europepmc   +1 more source

Role of Triglyceride-Glucose Index in Type 2 Diabetes Mellitus and Its Complications [PDF]

Ying Pan,1 Mengjie Zhao,1 Tiantian Song,2 Jia Tang,2 Ming Kuang,2 Hongying Liu,2,* Shao Zhong3,* 1Department of General Practice, Kunshan Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu, People’s Republic of China; 2Hangzhou Kang Ming
Liu H, Tang J, Zhao M, Pan Y, Zhong S, Song T, Kuang M   +6 more
core  

Cytokine Pathways Driving Diverse Tissue Pathologies in Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Rheumatoid arthritis (RA) is a complex systemic disorder characterized primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease, such as that of the lung, with potentially devastating clinical consequences. The critical importance of comorbidities,
Aurelie Najm, Lyn D. Ferguson, Iain B. McInnes   +2 more
wiley   +1 more source

Comparative evaluation of LDL-cholesterol estimation using machine learning algorithms and conventional equations in a large middle eastern cohort. [PDF]

Clinics (Sao Paulo)
Ahmed FS, Ahmad MI, Begum M, Rao D, Joan S.   +4 more
europepmc   +1 more source

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety Up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial

Arthritis &Rheumatology, EarlyView.
Objective To assess the efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with psoriatic arthritis (PsA) who were naive to biologic disease‐modifying antirheumatic drugs or received tumor necrosis factor inhibitors. Methods In the 52‐week, double‐blind, placebo‐controlled, phase 3 Program for Evaluation
Philip J. Mease, Vinod Chandran, April W. Armstrong, Ricardo Blanco, Alexis Ogdie, Evan L. Siegel, Alice B. Gottlieb, Xiaofeng Zeng, Diamant Thaçi, Mitsumasa Kishimoto, Hendrik Schulze‐Koops, Alan Kivitz, Eva Dokoupilová, Akimichi Morita, Eric M. Ruderman, Michael Plewinski, Kejia Wang, Caroline Sardinas, Eleni Vritzali, John Vaile, Atul Deodhar   +20 more
wiley   +1 more source

Blood Lipid Levels and Their Value as Markers of Disease Activity in Severe Ulcerative Colitis

International Journal of General Medicine
Lingling Zhu,1– 3 Linglin Tian,3 Suxia Li,1 Lijuan Huo3 1First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China; 2Linfen Vocational and Technical College, Linfen, Shanxi, People’s Republic of China ...
Zhu L, Tian L, Li S, Huo L
doaj